Does CDK4/6 inhibitor therapy treat hormone receptor-positive breast cancer?

Whether it belongs in a person's plan depends on the tumour's receptor results, stage, previous treatment, menopausal status, other health conditions, and the specific medicine being considered.

CDK4 and CDK6 are proteins that help cells move through the cycle of growth and division. Blocking them can slow the division of susceptible breast cancer cells. Endocrine therapy works through the hormone pathway, so the medicines address different signals that support tumour growth.

These tablets are used in particular early-stage or advanced treatment settings. The oncology team chooses a regimen by reviewing pathology, cancer extent, prior endocrine therapy, recurrence risk, and possible interactions with other medicines.

Take the medicine on the schedule provided and follow the instructions for missed doses. Before starting any prescription, over-the-counter product, or supplement, check for interactions with the oncology team or cancer pharmacist.

Attend scheduled blood tests and other checks. Monitoring may include blood cell counts, liver tests, heart rhythm assessment, or review for lung symptoms, depending on the selected drug and the person's medical history. Record diarrhoea, fatigue, mouth problems, appetite changes, or other new effects so the team can adjust supportive care.

Contact the oncology service promptly for fever, chills, or feeling acutely unwell because treatment can lower infection-fighting blood cells. Urgent advice is also needed for persistent or severe diarrhoea, inability to keep fluids down, yellowing of the skin or eyes, dark urine, new shortness of breath, chest pain, fainting, or a fast or irregular heartbeat.

Call emergency services for severe breathing difficulty, collapse, or chest pain with marked weakness. Bring the medicine list and oncology contact details so the receiving team can identify the treatment quickly.

Ask which receptor and pathology results support this treatment, which endocrine medicine will accompany it, what monitoring applies to the chosen drug, which interactions to avoid, how side effects will be managed, and what findings might lead to a dose pause or change.